COMP <GO>
ACU vs EML // RETURN ON INVESTED CAPITAL (ROIC)
Acme United Corporation. (NYSE) VS. Eastern Company (NASDAQ) • 15-METRIC TALLY: ACU 10
— EML 3
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: ACU
LAST: $68.11 (+1.89%) • MKT CAP: $261.1M
roic
9.20%
LAST: $27.67 (+3.25%) • MKT CAP: $166.5M
roic
5.60%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ACU VS. EML)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ACU | EML | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.40% | 22.90% | +16.50 | ACU | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | 9.20% | 5.60% | +3.60 | ACU | /roic <GO> |
| EV/EBITDA & P/E Valuation | 11.3x | 13.7x | -2.40 | ACU | /valuation <GO> |
| Free Cash Flow Yield | 2.90% | 2.94% | -0.04 | EML | /fcf-yield <GO> |
| Operating Margin | 7.50% | 4.30% | +3.20 | ACU | /operating-margins <GO> |
| Net Profit Margin | 5.20% | 2.90% | +2.30 | ACU | /net-margins <GO> |
| Revenue Growth (YoY) | 1.10% | -8.70% | +9.80 | ACU | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.90% | 1.61% | -0.71 | EML | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 5.72 | 3.69 | +2.03 | ACU | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | ACU | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 69.7 | 66.1 | +3.60 | ACU | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 23.8x | 21.7x | +2.10 | EML | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $261.1M | $166.5M | $94.6M | ACU | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ACU REV | EML REV | ACU GROSS % | EML GROSS % | ACU FCF | EML FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $196.5M | $249.0M | 39.4% | 22.9% | $7.6M | $4.9M |
| FY 2024 | $194.5M | $272.8M | 39.3% | 24.7% | $4.8M | $9.7M |
| FY 2023 | $191.5M | $258.9M | — | — | $28.9M | $25.5M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ACU // BETA —
EML // BETA —